Connect with us

Top Stories

The FDA hopes to fully approve the Pfizer-BioNTech vaccine on Monday, The New York Times reported

The FDA is pushing to approve the Pfizer-BioNTech vaccine on Monday, according to The New York Times. The Food and Drug Administration is planning to authorize full approval of the Pfizer-BioNTech two-dose COVID-19 vaccine on Monday, according to The New York Times. Health experts, too, are eager for an FDA-approved vaccine, in hopes that it will convince some skeptical Americans who have been holding out for a fully authorized shot to get vaccinated.

View Full Article

Disclaimer

This news content is a computer generated summarized version of the original article and the authenticity of the original content has not been verified. Please click on the View Article button to refer to the actual content. 

Trending